283 related articles for article (PubMed ID: 26096891)
61. A computational approach yields selective inhibitors of human excitatory amino acid transporter 2 (EAAT2).
Damm-Ganamet KL; Rives ML; Wickenden AD; McAllister HM; Mirzadegan T
J Biol Chem; 2020 Mar; 295(13):4359-4366. PubMed ID: 32079674
[TBL] [Abstract][Full Text] [Related]
62. Neuronal stimulation leading to upregulation of glutamate transporter-1 (GLT-1) in rat microglia in vitro.
Nakajima K; Yamamoto S; Kohsaka S; Kurihara T
Neurosci Lett; 2008 May; 436(3):331-4. PubMed ID: 18406522
[TBL] [Abstract][Full Text] [Related]
63. Ceftriaxone alleviates early brain injury after subarachnoid hemorrhage by increasing excitatory amino acid transporter 2 expression via the PI3K/Akt/NF-κB signaling pathway.
Feng D; Wang W; Dong Y; Wu L; Huang J; Ma Y; Zhang Z; Wu S; Gao G; Qin H
Neuroscience; 2014 May; 268():21-32. PubMed ID: 24631672
[TBL] [Abstract][Full Text] [Related]
64. Translational control of glial glutamate transporter EAAT2 expression.
Tian G; Lai L; Guo H; Lin Y; Butchbach ME; Chang Y; Lin CL
J Biol Chem; 2007 Jan; 282(3):1727-37. PubMed ID: 17138558
[TBL] [Abstract][Full Text] [Related]
65. Neuroprotection by rosiglitazone in transient focal cerebral ischemia might not be mediated by glutamate transporter-1.
Verma R; Mishra V; Gupta K; Sasmal D; Raghubir R
J Neurosci Res; 2011 Nov; 89(11):1849-58. PubMed ID: 21826699
[TBL] [Abstract][Full Text] [Related]
66. Harmine mediated neuroprotection via evaluation of glutamate transporter 1 in a rat model of global cerebral ischemia.
Sun P; Zhang S; Li Y; Wang L
Neurosci Lett; 2014 Nov; 583():32-6. PubMed ID: 25238961
[TBL] [Abstract][Full Text] [Related]
67. Pharmacological evidence for the concept of spare glutamate transporters.
Belo do Nascimento I; Damblon J; Ingelbrecht C; Goursaud S; Massart M; Dumont A; Desmet N; Hermans E
Neurochem Int; 2021 Oct; 149():105142. PubMed ID: 34314789
[TBL] [Abstract][Full Text] [Related]
68. WAY-855 (3-amino-tricyclo[2.2.1.02.6]heptane-1,3-dicarboxylic acid): a novel, EAAT2-preferring, nonsubstrate inhibitor of high-affinity glutamate uptake.
Dunlop J; Eliasof S; Stack G; McIlvain HB; Greenfield A; Kowal D; Petroski R; Carrick T
Br J Pharmacol; 2003 Nov; 140(5):839-46. PubMed ID: 14517179
[TBL] [Abstract][Full Text] [Related]
69. Evoked expression of the glutamate transporter GLT-1c in retinal ganglion cells in human glaucoma and in a rat model.
Sullivan RK; Woldemussie E; Macnab L; Ruiz G; Pow DV
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3853-9. PubMed ID: 16936097
[TBL] [Abstract][Full Text] [Related]
70. Methylmercury alters the in vitro uptake of glutamate in GLAST- and GLT-1-transfected mutant CHO-K1 cells.
Mutkus L; Aschner JL; Syversen T; Aschner M
Biol Trace Elem Res; 2005 Dec; 107(3):231-45. PubMed ID: 16286679
[TBL] [Abstract][Full Text] [Related]
71. Loss of SIRT4 decreases GLT-1-dependent glutamate uptake and increases sensitivity to kainic acid.
Shih J; Liu L; Mason A; Higashimori H; Donmez G
J Neurochem; 2014 Dec; 131(5):573-81. PubMed ID: 25196144
[TBL] [Abstract][Full Text] [Related]
72. Inhibition of p38 MAPK Signaling Regulates the Expression of EAAT2 in the Brains of Epileptic Rats.
Yang Z; Wang J; Yu C; Xu P; Zhang J; Peng Y; Luo Z; Huang H; Zeng J; Xu Z
Front Neurol; 2018; 9():925. PubMed ID: 30429824
[TBL] [Abstract][Full Text] [Related]
73. Astrocytic glutamate transporter-dependent neuroprotection against glutamate toxicity: an in vitro study of maslinic acid.
Qian Y; Guan T; Tang X; Huang L; Huang M; Li Y; Sun H; Yu R; Zhang F
Eur J Pharmacol; 2011 Jan; 651(1-3):59-65. PubMed ID: 21118675
[TBL] [Abstract][Full Text] [Related]
74. Excitatory Amino Acid Transporters in Physiology and Disorders of the Central Nervous System.
Malik AR; Willnow TE
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31726793
[TBL] [Abstract][Full Text] [Related]
75. Molecular pharmacology of glutamate transporters, EAATs and VGLUTs.
Shigeri Y; Seal RP; Shimamoto K
Brain Res Brain Res Rev; 2004 Jul; 45(3):250-65. PubMed ID: 15210307
[TBL] [Abstract][Full Text] [Related]
76. The Neuroprotective Effect of the Association of Aquaporin-4/Glutamate Transporter-1 against Alzheimer's Disease.
Lan YL; Zou S; Chen JJ; Zhao J; Li S
Neural Plast; 2016; 2016():4626593. PubMed ID: 27057365
[TBL] [Abstract][Full Text] [Related]
77. Neurobiology, Functions, and Relevance of Excitatory Amino Acid Transporters (EAATs) to Treatment of Refractory Epilepsy.
Zaitsev AV; Smolensky IV; Jorratt P; Ovsepian SV
CNS Drugs; 2020 Nov; 34(11):1089-1103. PubMed ID: 32926322
[TBL] [Abstract][Full Text] [Related]
78. Differential regulation of 5' splice variants of the glutamate transporter EAAT2 in an in vivo model of chemical hypoxia induced by 3-nitropropionic acid.
Münch C; Zhu BG; Leven A; Stamm S; Einkörn H; Schwalenstöcker B; Ludolph AC; Riepe MW; Meyer T
J Neurosci Res; 2003 Mar; 71(6):819-25. PubMed ID: 12605408
[TBL] [Abstract][Full Text] [Related]
79. Glutamate Transport and Preterm Brain Injury.
Pregnolato S; Chakkarapani E; Isles AR; Luyt K
Front Physiol; 2019; 10():417. PubMed ID: 31068830
[TBL] [Abstract][Full Text] [Related]
80. Proteome analysis and conditional deletion of the EAAT2 glutamate transporter provide evidence against a role of EAAT2 in pancreatic insulin secretion in mice.
Zhou Y; Waanders LF; Holmseth S; Guo C; Berger UV; Li Y; Lehre AC; Lehre KP; Danbolt NC
J Biol Chem; 2014 Jan; 289(3):1329-44. PubMed ID: 24280215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
